series-c-plus
Stage
1
Investors
About
Proteostasis Therapeutics develops small-molecule therapies that modulate the cellular proteostasis network to restore function of misfolded proteins, targeting diseases such as cystic fibrosis and other protein-misfolding disorders.
Explore Proteostasis Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.